患有COPD的年轻患者急性恶化和疾病进展的危险因素
Juye Bae1, Hyo Jin Lee2, Kwang Yong Choi3
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Seoul, Korea (the Republic of).
BMJ open respiratory research
|July 17, 2024
概括
喘病史,肺气和高乙酸细胞计数预测年轻的COPD患者的恶化. 以前的呼吸道疾病和症状也表明疾病进展和早期治疗需要.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 呼吸系统研究 呼吸系统研究
背景情况:
- 慢性阻塞性肺病 (COPD) 通常影响老年人,但年轻患者的一个子集经历了显著的疾病负担.
- 在年轻的COPD患者中确定恶化和进展的早期临床预测因素对于及时干预至关重要.
研究的目的:
- 确定与20-50岁的COPD患者急性恶化和疾病进展相关的临床因素.
- 为了确定中度至严重恶化的风险因素,早期启动吸入疗法,以及加速的肺功能下降.
主要方法:
- 在342名慢性肺炎患者 (20-50岁) 中进行了回顾性纵向观察性研究,后支气管扩展剂FEV1/FVC<0.7.7.
- 随访包括诊断后1年间隔至少两次螺旋计测试.
- 多变量分析评估了主要 (恶化) 和次要结果 (治疗开始,FEV1下降) 的风险因素.
主要成果:
- 喘病史 (aHR=2.999),肺气 (aHR=1.951),血中乙氨基 >300/μL (aHR=1.469),以及低FEV1% (aHR=0.979) 与恶化有关.
- 喘病史,唾液,高乙酸细胞,低FEV1%,低DLCO%预测了早期的吸入治疗.
- 增加年龄,女性性别,先前结核病,吐,低FEV1%和低DLCO%与更快的FEV1下降有关.
结论:
- 年轻的COPD患者有喘病史,肺气,血中乙氨基升高或FEV1%低,面临着更高的恶化风险.
- 过去的呼吸道疾病,当前的症状,乙酸细胞计数和肺功能障碍是年轻COPD患者疾病进展和早期治疗的关键指标.
相关概念视频
COPD: Pathogenesis and Clinical Features
252
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
252
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
194
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
194


